Blow-Fill-Seal technology and vaccine delivery

by Biotech Newsroom


In this context of sanitary crisis, Unither Pharmaceuticals, a BFS leader with almost 30 years of experience, launched Euroject® in Sept. 2021 combining a BFS unit-dose vial with a needle hub for vaccine injection. This new device goes with a dedicated BSL2 workshop, based in Amiens (FR), which will be able by 2024 to fill 1 billion doses annually. Meanwhile, all internal and customer development tests are performed on an industrial full-size BottlePack (BP) 460 machine in Coutances (FR).

BFS history
BFS technology is originally derived from a 1963 patent application. At that time, the concept allowed the packaging of food, cosmetics, and medical…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC